The nanocarrier possess excellent siRNA-loading efficiency (∼80% of dose), and efficiently induced vascular endothelial growth factor (VEGF) mRNA knockdown (∼80%) in pancreatic cancer cells (Panc-1) [69]. The gene discussed is VEGFA; the disease is pancreatic neoplasm.